Literature DB >> 23959438

The reproducibility of cardiac and liver T2* measurement in thalassemia major using two different software packages.

Sophie Mavrogeni1, Konstantinos Bratis, Kees van Wijk, Louisa Kyrou, Antonios Kattamis, Johan H C Reiber.   

Abstract

In b-thalassemia major (TM) multiple blood transfusions are needed for survival. As a consequence these patients present iron overload in different organs, including heart and liver. Magnetic resonance imaging using a bright blood gradient echo sequence has been successfully used for the quantification of tissue iron. The aim is to evaluate of the accuracy and precision in the evaluation of liver and myocardial T2* values in TM using two different analytical software solutions. Thirty TM patients aged 20-56 years (mean age 37, 11M/19F) were scanned in a GE 1.5 T CVI system. Each scan included the measurement of heart and liver T2* and the left ventricular ejection fraction using standard techniques. The analysis of T2* of heart and liver was done using the two different analytical software solutions: the "Functool" protocol by GE and the T2* module of QMassMR v7.4 by Medis medical imaging systems bv, Leiden, The Netherlands. The cardiac and liver T2* measurements showed that both software solutions allow reproducible measurements with low intra-observer variations (accuracy < 0.3 ms, precision < 2 ms). There is a small but significant difference between the two solutions of 2.4 ms in cardiac and of 1.5 ms in liver measurements. However, from the clinical point of view these differences (<2 ms) are small with negligible impact on the patient's treatment management. The comparison of the T2* measurements using the two analytical software solutions proved that both techniques enable reproducible measurements for the evaluation of iron overload in heart and liver.

Entities:  

Year:  2013        PMID: 23959438     DOI: 10.1007/s10554-013-0242-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  20 in total

1.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients.

Authors:  John C Wood; Cathleen Enriquez; Nilesh Ghugre; J Michael Tyzka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

2.  A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.

Authors:  M A Tanner; R Galanello; C Dessi; G C Smith; M A Westwood; A Agus; M Roughton; R Assomull; S V Nair; J M Walker; D J Pennell
Journal:  Circulation       Date:  2007-03-19       Impact factor: 29.690

3.  Editorial: Serum ferritin fails to indicate hemochromatosis--nothing gold can stay.

Authors:  W H Crosby
Journal:  N Engl J Med       Date:  1976-02-05       Impact factor: 91.245

4.  Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron.

Authors:  Anna Ramazzotti; Alessia Pepe; Vincenzo Positano; Giuseppe Rossi; Daniele De Marchi; Maria Gabriella Brizi; Antongiulio Luciani; Massimo Midiri; Giuseppina Sallustio; Gianluca Valeri; Vincenzo Caruso; Michele Centra; Paolo Cianciulli; Vincenzo De Sanctis; Aurelio Maggio; Massimo Lombardi
Journal:  J Magn Reson Imaging       Date:  2009-07       Impact factor: 4.813

5.  Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia.

Authors:  Mark A Westwood; David N Firmin; Matta Gildo; Galanello Renzo; Gotsis Stathis; Karagiorga Markissia; Berdoukas Vasili; Dudley J Pennell
Journal:  Int J Cardiovasc Imaging       Date:  2005-10       Impact factor: 2.357

6.  Measurement of liver-iron concentration in needle-biopsy specimens.

Authors:  M Barry; S Sherlock
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

7.  Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.

Authors:  Dudley J Pennell; Vasili Berdoukas; Markissia Karagiorga; Vasili Ladis; Antonio Piga; Athanassios Aessopos; Efstathios D Gotsis; Mark A Tanner; Gill C Smith; Mark A Westwood; Beatrix Wonke; Renzo Galanello
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

8.  Comparison of the region-based and pixel-wise methods for cardiac T2* analysis in 50 transfusion-dependent Thai thalassemia patients.

Authors:  Pairash Saiviroonporn; Vip Viprakasit; Thananya Boonyasirinant; Archrob Khuhapinant; John C Wood; Rungroj Krittayaphong
Journal:  J Comput Assist Tomogr       Date:  2011 May-Jun       Impact factor: 1.826

9.  Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model.

Authors:  P Liu; M Henkelman; J Joshi; P Hardy; J Butany; M Iwanochko; M Clauberg; M Dhar; D Mai; S Waien; N Olivieri
Journal:  Can J Cardiol       Date:  1996-02       Impact factor: 5.223

10.  Value of black blood T2* cardiovascular magnetic resonance.

Authors:  Gillian C Smith; John Paul Carpenter; Taigang He; Mohammed H Alam; David N Firmin; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2011-03-14       Impact factor: 5.364

View more
  7 in total

Review 1.  Cardiovascular imaging 2013 in the International Journal of Cardiovascular Imaging.

Authors:  Hiram G Bezerra; Ricardo A Costa; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire
Journal:  Int J Cardiovasc Imaging       Date:  2014-04       Impact factor: 2.357

2.  Comparison between different software programs and post-processing techniques for the MRI quantification of liver iron concentration in thalassemia patients.

Authors:  Lorenzo Bacigalupo; Francesco Paparo; Daniele Zefiro; Carlo Maria Viberti; Luca Cevasco; Barbara Gianesin; Valeria Maria Pinto; Gian Andrea Rollandi; John C Wood; Gian Luca Forni
Journal:  Radiol Med       Date:  2016-06-22       Impact factor: 3.469

3.  Quantification in cardiovascular magnetic resonance: agreement of software from three different vendors on assessment of left ventricular function, 2D flow and parametric mapping.

Authors:  Leonora Zange; Fabian Muehlberg; Edyta Blaszczyk; Susanne Schwenke; Julius Traber; Stephanie Funk; Jeanette Schulz-Menger
Journal:  J Cardiovasc Magn Reson       Date:  2019-02-21       Impact factor: 5.364

4.  Contrast-optimized composite image derived from multigradient echo cardiac magnetic resonance imaging improves reproducibility of myocardial contours and T2* measurement.

Authors:  Pandji Triadyaksa; Astri Handayani; Hildebrand Dijkstra; Kadek Y E Aryanto; Gert Jan Pelgrim; Xueqian Xie; Tineke P Willems; Niek H J Prakken; Matthijs Oudkerk; Paul E Sijens
Journal:  MAGMA       Date:  2015-11-03       Impact factor: 2.310

5.  Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.

Authors:  G J H Snel; M van den Boomen; L M Hernandez; C T Nguyen; D E Sosnovik; B K Velthuis; R H J A Slart; R J H Borra; N H J Prakken
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

Review 6.  Cardiac T2 * mapping: Techniques and clinical applications.

Authors:  Pandji Triadyaksa; Matthijs Oudkerk; Paul E Sijens
Journal:  J Magn Reson Imaging       Date:  2019-12-14       Impact factor: 4.813

7.  The effect of measurement area size on the reliability of myocardial iron load measurement in cardiac magnetic resonance imaging examinations of thalassemia patients

Authors:  İbrahim Önder Yeniçeri; Fatih Mehmet Azık; Funda Dinç Elibol
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.